benzoylarginine ethyl ester has been researched along with gallic acid in 3 studies
| Studies (benzoylarginine ethyl ester) | Trials (benzoylarginine ethyl ester) | Recent Studies (post-2010) (benzoylarginine ethyl ester) | Studies (gallic acid) | Trials (gallic acid) | Recent Studies (post-2010) (gallic acid) |
|---|---|---|---|---|---|
| 111 | 0 | 15 | 4,793 | 42 | 2,579 |
| Protein | Taxonomy | benzoylarginine ethyl ester (IC50) | gallic acid (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Tissue-type plasminogen activator | Homo sapiens (human) | 6.6 | |
| Plasminogen activator inhibitor 1 | Homo sapiens (human) | 6.6 | |
| Urokinase-type plasminogen activator | Mus musculus (house mouse) | 6.6 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 4.03 | |
| Matrilysin | Homo sapiens (human) | 4.03 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 4.65 | |
| Alpha-synuclein | Homo sapiens (human) | 4.43 | |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | Homo sapiens (human) | 4.03 | |
| Polypeptide N-acetylgalactosaminyltransferase 2 | Homo sapiens (human) | 1.37 | |
| Alpha-(1,3)-fucosyltransferase 7 | Homo sapiens (human) | 4.03 | |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | Homo sapiens (human) | 4.03 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SJ; Hwang, JH | 1 |
| Cai, W; Ma, G; Sha, X; Shi, X; Zheng, Y; Zhu, Q; Zhu, Y | 1 |
| Ding, Q; Lu, C; Lu, T; Sun, Y; Yuan, Y; Zhang, X | 1 |
3 other study(ies) available for benzoylarginine ethyl ester and gallic acid
| Article | Year |
|---|---|
Reduction of neuronal damage in ischemic stroke using a combination therapy of TMB-8 with L-arginine.
Topics: Animals; Arginine; Brain Ischemia; Calcium; Calcium Channel Blockers; Drug Therapy, Combination; Gallic Acid; Necrosis; Nitric Oxide Synthase; Rats; Rats, Long-Evans; Tumor Cells, Cultured | 2000 |
Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats.
Topics: Animals; Arginine; Calibration; Cardiovascular Agents; Chromatography, High Pressure Liquid; Gallic Acid; Leonurus; Limit of Detection; Male; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry | 2012 |
A study on the PK and BA profiles in the mouse body for leonurine O/O microemulsion with determination by the LC-MS/MS method.
Topics: Administration, Oral; Animals; Arginine; Biological Availability; Chromatography, High Pressure Liquid; Drug Delivery Systems; Emulsions; Gallic Acid; Mice; Solubility; Suspensions; Tandem Mass Spectrometry; Water | 2016 |